RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 1:45 AM
Followers: 435
Posts Today: 0
Views Today: 3728

CYDY Stock Quote & Tools

$0.2137 ▲ +0.0037 (+1.77%) As of Sep 18, 3:59 PM EDT
Last0.2137
$ Chg0.0037
Open0.2100
High0.2140
Beta1.2374
Year High0.397
Market Cap295.35M
P/B Ratio-2.69
EPS-0.03
Avg Vol (30d)1.51M
Volume900.1K
% Chg+1.77%
Prev Close0.2100
Low0.2045
VWAP0.21008
Year Low0.183
Total Shares1.38B
Shares Out1.38B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

4 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab - Disease List (currently 90) (updated 12-09-2021) An incomplete list of potential (40) by ohm20
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. lorbas

    In the email it was "a few weeks away", at 4:20 in the MoneyTalk Station interview he says "few"

  2. trding

    Not sure, I thought he said two weeks. I would have to listen again. Last proactive video I

  3. lorbas

    Didn't he say a few/couple of weeks?

  4. trding

    I suspect many are with you. He did say if a video a couple weeks ago, they extended the nda by

  5. trding

    Understood, just my opinion. One or the other gets done, it will probably be enough to appease the

    (1)
  6. Evil Rabbit

    Personally, Im done defending NP. Hes missed too many deadlines and mislead us too many

    (1)
  7. lorbas

    Make that an AND, not an OR. Not convinced that BLA submission alone will prop up SP enough to

    (2)
  8. misiu143

    Trding , I feel the same , today was a first time I felt more confused after listening to the video

  9. JmcII

    Frankly he needs to get both the deal and BLA done. Will need funding well into 2020. The BOD will

  10. trding

    I usually like the videos, as I learn new details, but todays was confusing. But BLA is on

    (1)
  11. BlackDoggie

    Children, please... go to your separate corners for time out. Everyone is frustrated with the

    (3)
  12. henry f

    Its not about what I can handle. I can (and will) simply put you on ignore. The question is

  13. lorbas

    I love those PAID videos that confuse everyone and leave us with more questions than answers.

    (2)
  14. ohm20

    From the video - They were initially basing their decision on treatment on CCR5 on the tumor cells,

  15. craigakess

    henry: Well, if all you can handle is a cheerleader, congrats on your trophies for just showing

    (1)
  16. henry f

    I think you need to find a different investment and a different message board. That would be a

    (2)
  17. JmcII

    Agree. He seems to insinuate he is 100% up front with the public and it maybe to his detriment.

    (1)
  18. Fortuno

    I'm not so sure he will, but also I'm not sure I would like him to do that. ;)

  19. trding

    Sometimes it helps, sometimes it helps:)

  20. JmcII

    If the deal is off does NP come out publicly and disclose it ? Not sure he does In his email to

  21. ohm20

    The science is based on all previous research that has been done on CCR5 and cancer and there's a

  22. misiu143

    That was very confusing to me , I send my questions to Marek , I hope I will have some answer .....

  23. Fortuno

    I don't think listening again will be of any help. :) I've got no clue what he's saying (if he's

    (2)
  24. trding

    Yeah, that was a confusing explanation, I have to listen again. No mention of the deal on first

  25. Fortuno

    Good for him I'm the exact opposite.

  26. Fortuno

    Why should he? Do we really want him to say that all's well but we've decided to practically

  27. plavac

    NP seemed very pleased and calm

  28. Evil Rabbit

    Not one word about financing. Grrrrr.

  29. lorbas

    I didn't really get that part... I thought there were multiple MOAs... Anyway, BLA seems on

    (1)
  30. LaundryMoney

    Interesting. Sounds like the August injection emergency access was stopped because her cancer was

  31. trding

    We are close to reaching the point that Cytodyn can't be ignored. Mono or cancer makes leronlimab

    (1)
  32. lorbas

    NEW VIDEO

    (1)
  33. Fortuno

    Absolutely ! ;)

    (1)
  34. trding

    craig: I believe he was commenting on the accent quote below, which may not be racist, there

    (3)
  35. lorbas

    Hey, come on: "NEXT SUPER STOCK!" is way more legit than "MICRO CAP RODEO"! ;)

    (2)
  36. Fortuno

    Thank you, I'm thrilled about it.

    (2)
  37. misiu143

    Trding , - In my very strong opinion , with those medical results in few , by now , but very

    (3)
  38. Hulk767

    Great post. I say we get thru BLA and see if we get financing deal by year end / Jan. Hopefully

    (1)
  39. lorbas

    NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter will be hosting the NEXT SUPER

    (3)
  40. craigakess

    Aidenb: Perhaps you're projecting, but nothing I said was racist at all. The size of someone

    (1)
  41. trding

    I'm not expecting a change course this close to BLA submission. Really, the only decision we have

    (1)
  42. aidenb

    but if it's NP's accent that makes you all wet and wiggly for CYDY, to each his own. Read

    (1)
  43. craigakess

    Aiden: If you think it's that black or white based on a whim and not facts, then I sincerely hope

    (2)
  44. aidenb

    An intelligent approach by a shareholder would be to be in a stock or not. Normal common

    (1)
  45. craigakess

    Gereractor: Exactly, and venting is normal and necessary, especially if one is starting to feel

    (1)
  46. craigakess

    Aidenb: Are you being a jerk or am I misconstruing your question? I am a shareholder. I am

    (2)
  47. craigakess

    Hulk: Understood, and please know that I am NOT saying "Just get the deal done." I work in

    (3)
  48. generactor

    What can any of us do?

    (1)
  49. aidenb

    What has happened to this board. Guy is repeating himself like a broken clock. Is there a better

  50. aidenb

    We are cutting him waaaaay too much slack If you don't mind, who were you agai

    (1)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading